Blood glucose concentrations of tilapia in different experimental groups (control, stress, prevention, and treatment) were examined. by Sinthia Kabir Mumu (17705902)

Computational analysis of pediatric ventricular assist device implantation to decrease cerebral particulate embolization by ThuyTien Nguyen (775693)

Decrease in DA uptake activity in striatal synaptosomes of <i>Ptprz-</i>KO mice. by Akihiro Fujikawa (122649)

Reishi decreases EIF4F complex levels and protein synthesis in IBC cells. by Ivette J. Suarez-Arroyo (383847)

Diurnal Glycemic Patterns during an 8-Week Open-Label Proof-of-Concept Trial of Empagliflozin in Type 1 Diabetes by Bruce A. Perkins (312635)

“…</p><p>Results</p><p>The 40 patients (26 on insulin pump) were aged 24±5 years and BMI 24.5±3.2 kg/m². Consistent with the observed HbA1c decrease (8.0±0.9% to 7.6±0.9%, p<0.0001), normalized AUC_TOTAL CGM decreased from 153.7±25.4 to 149.0±30.2mg/dL∙h at end-of-treatment (p = 0.31), and significantly increased post-treatment (164.1±29.5mg/dL∙h, p = 0.02). …”

Anti-EBOV GP IgGs Lacking α1-3-Galactose and Neu5Gc Prolong Survival and Decrease Blood Viral Load in EBOV-Infected Guinea Pigs by Olivier Reynard (354756)

“…In this paper, we explored whether low immunogenicity IgGs had a protective effect on a guinea pig model of Ebola virus (EBOV) infection. …”

Effect of decreased renal function and immunosuppressive agents on circulating levels of progenitor cells in rats. by Giovana S. Di Marco (206524)

Agroinfiltration decreases ABA levels and primes callose deposition in <i>N. tabacum</i>. by Arantza Rico (242246)

Data Supplement from Decreased Expression of Cystathionine β-Synthase Promotes Glioma Tumorigenesis by Naoharu Takano (15079957)

PDGF-BB-induced NR4A1 expression is decreased after treatment with the NF-κB inhibitor BAY11-7082. by Glenda Eger (636934)

Figure 1 Exogenous serotonin inhibits the Dar phenotype and decreases pathogen clearance rates by Rachel Mcmullan (506214)

“…<p>Adult wild type animals were exposed to M. nematophilum on plates containing exogenous serotonin and the Dar phenotype was scored in their progeny. Treatment with 3.8mg/ml 5-HT caused a 35% decrease in the number of Dar animals following M. nematophilum infection using standard assay conditions (small lawn) (A). …”

A C5a-Immunoglobulin complex in chronic lymphocytic leukemia patients is associated with decreased complement activity by Regina Michelis (2889092)

“…In patients with abnormal C5, basal levels of sC5b-9 and C5a were increased while activities of the CP and of the CP C5-convertase, the immediate C5-upstream complex, were decreased compared to NC and to patients with normal C5. …”

Anti-TGFβ antibody treatment decreases tumor burden in tumor-bearing mice. by Swati Biswas (73661)

“…White line indicates the presence of tumor. <b>Panel b:</b> A boxplot of tumor burden in MDA-MB-231 tumor-bearing mice treated with either 13C4 (10 mg/kg) or 1D11(10 mg/kg) for 4 weeks, starting 1 day after tumor cell injection (N = at least 7) showing decrease in tumor burden. …”

L665W decreased AR5A binding to H77/JFH1 particles and to the E1/E2 complex in H77/JFH1 infected cells, but did not alter receptor dependency. by Rodrigo Velázquez-Moctezuma (3776023)

Flies decrease the level of aggression as the availability of food resource increases. by Rod S. Lim (622045)

53BP1 protein content decreases upon irradiation is due to protein degradation. by Yiheng Hu (648082)

Decreased cell growth of PGRN knock-out cell line as determined by the MTT assay. by Weifeng Zhang (134361)

TGFβ1 and COL1A1 expression was decreased and RASAL1 expression was increased by Western blotting in NTM cells under both normoxic and hypoxic conditions. by Fiona McDonnell (2636635)

“…We found that COL1A1 protein was decreased in the presence of 5-aza. …”

Genistein decreases mouse liver lnfection by <i>P. berghei</i> ANKA sporozoites. by Margarida Cunha-Rodrigues (65513)

Enalaprilat and losartan decrease erythroid precursors frequency in cells from patients with polycythemia vera by Angela Bozza (8908091)

“…After the discovery of a mutation in the Janus kinase 2 (<i>JAK</i>2^V617F), JAK2 inhibitors have been tested as second-line therapies. …”